Search Results 961-970 of 17029 for First%2Baid
Validation Of Early Prognostic Data For Recovery Outcome After Stroke For Future, Higher Yield Trials. Rochester, Minn. VERIFY will validate biomarkers of upper ...
Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to ...
Mayo Clinic First to Show Virotherapy is Promising Against Multiple Myeloma (pkg). Robert Nellis. May 16, 2014. First · Previous ... 334 · 335 · 336 · 337 · 338 ...
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection ...
Early detection is critical for development of interventions to halt, slow, or even reverse these pathological processes. The promise of plasma biomarkers to ...
First · 1 · 2 · 3 · 4 ... Next · Last. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery Science · Healthcare Delivery ...
Latest stories · Research connects first-time kidney stone formers and chronic kidney disease featured image · Single mutation in recessive gene increases risk of ...
... first 50 Exposure Days (ED). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.